KLKB1
MOLECULAR TARGETkallikrein B1
KLKB1 (kallikrein B1) is targeted by 6 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting KLKB1
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | leupeptin | 3.40 | 29 |
| 2 | gw813893 | 1.95 | 6 |
| 3 | Gabexate | 0.69 | 1 |
| 4 | bdb chembl4435573 | 0.69 | 1 |
| 5 | bdb chembl4439549 | 0.69 | 1 |
| 6 | bdb r 3 phenyl 1 s 2 phenyl 1 3 3 3 trifluoro 1 4 guanidino benzyl 2 oxo propylcarba | 0.69 | 1 |
About KLKB1 as a Drug Target
KLKB1 (kallikrein B1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 6 compounds with documented KLKB1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
KLKB1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.